Officials for J&J announced the FDA’s decision during a company conference call after the company released its first quarter results, according to the report. The FDA sent the company a “Not Approvable” letter, along with suggestions the company could consider for the product.
J&J is appealing the FDA’s decision. The anesthesia system is made by J&J Ethicon EndoSurgery division and is approved for use in the European Union for upper GI procedures and colonoscopy and for colonoscopy in Canada, according to the report.
Read the AP’s report on the FDA’s rejection of J&J’s computer-assisted anesthesia device.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
